APA način citiranja

Cai, W., Cai, B., Zhou, J., Chen, Y., Zhang, J., Huang, Y., . . . Huang, J. (2019). Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: A retrospective study. Cancer Commun (Lond).

Čikaški stil citiranja

Cai, Wen, Biao Cai, Juan Zhou, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue, i Jiwei Huang. "Comparison of Efficacy and Safety Among Axitinib, Sunitinib, and Sorafenib As Neoadjuvant Therapy for Renal Cell Carcinoma: A Retrospective Study." Cancer Commun (Lond) 2019.

MLA način citiranja

Cai, Wen, et al. "Comparison of Efficacy and Safety Among Axitinib, Sunitinib, and Sorafenib As Neoadjuvant Therapy for Renal Cell Carcinoma: A Retrospective Study." Cancer Commun (Lond) 2019.